Literature DB >> 30197073

Eosinophilic Esophagitis.

Benjamin L Wright1, Jonathan M Spergel2.   

Abstract

Entities:  

Mesh:

Year:  2018        PMID: 30197073      PMCID: PMC7263475          DOI: 10.1016/j.jaip.2018.06.019

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


× No keyword cloud information.
  16 in total

1.  An antibody against IL-5 reduces numbers of esophageal intraepithelial eosinophils in children with eosinophilic esophagitis.

Authors:  Amal H Assa'ad; Sandeep K Gupta; Margaret H Collins; Mike Thomson; Amy T Heath; Deborah A Smith; Teresa L Perschy; Cynthia H Jurgensen; Hector G Ortega; Seema S Aceves
Journal:  Gastroenterology       Date:  2011-08-09       Impact factor: 22.682

2.  Long-Term Treatment of Eosinophilic Esophagitis With Swallowed Topical Corticosteroids: Development and Evaluation of a Therapeutic Concept.

Authors:  Thomas Greuter; Christian Bussmann; Ekaterina Safroneeva; Alain M Schoepfer; Luc Biedermann; Stephan R Vavricka; Alex Straumann
Journal:  Am J Gastroenterol       Date:  2017-07-18       Impact factor: 10.864

3.  Identification of causative foods in children with eosinophilic esophagitis treated with an elimination diet.

Authors:  Jonathan M Spergel; Terri F Brown-Whitehorn; Antonella Cianferoni; Michele Shuker; Mei-Lun Wang; Ritu Verma; Chris A Liacouras
Journal:  J Allergy Clin Immunol       Date:  2012-06-27       Impact factor: 10.793

4.  Reslizumab in children and adolescents with eosinophilic esophagitis: results of a double-blind, randomized, placebo-controlled trial.

Authors:  Jonathan M Spergel; Marc E Rothenberg; Margaret H Collins; Glenn T Furuta; Jonathan E Markowitz; George Fuchs; Molly A O'Gorman; Juan Pablo Abonia; James Young; Timothy Henkel; H Jeffrey Wilkins; Chris A Liacouras
Journal:  J Allergy Clin Immunol       Date:  2011-12-28       Impact factor: 10.793

5.  Eosinophilic esophagitis in adults is associated with IgG4 and not mediated by IgE.

Authors:  Frederic Clayton; John C Fang; Gerald J Gleich; Alfredo J Lucendo; Jose M Olalla; Laura A Vinson; Amy Lowichik; Xinjian Chen; Lyska Emerson; Kristen Cox; Molly A O'Gorman; Kathryn A Peterson
Journal:  Gastroenterology       Date:  2014-06-04       Impact factor: 22.682

Review 6.  Eosinophilic esophagitis: updated consensus recommendations for children and adults.

Authors:  Chris A Liacouras; Glenn T Furuta; Ikuo Hirano; Dan Atkins; Stephen E Attwood; Peter A Bonis; A Wesley Burks; Mirna Chehade; Margaret H Collins; Evan S Dellon; Ranjan Dohil; Gary W Falk; Nirmala Gonsalves; Sandeep K Gupta; David A Katzka; Alfredo J Lucendo; Jonathan E Markowitz; Richard J Noel; Robert D Odze; Philip E Putnam; Joel E Richter; Yvonne Romero; Eduardo Ruchelli; Hugh A Sampson; Alain Schoepfer; Nicholas J Shaheen; Scott H Sicherer; Stuart Spechler; Jonathan M Spergel; Alex Straumann; Barry K Wershil; Marc E Rothenberg; Seema S Aceves
Journal:  J Allergy Clin Immunol       Date:  2011-04-07       Impact factor: 10.793

7.  Clinical and immunopathologic effects of swallowed fluticasone for eosinophilic esophagitis.

Authors:  Richard J Noel; Philip E Putnam; Margaret H Collins; Amal H Assa'ad; Jesus R Guajardo; Sean C Jameson; Marc E Rothenberg
Journal:  Clin Gastroenterol Hepatol       Date:  2004-07       Impact factor: 11.382

8.  Clinical and endoscopic characteristics do not reliably differentiate PPI-responsive esophageal eosinophilia and eosinophilic esophagitis in patients undergoing upper endoscopy: a prospective cohort study.

Authors:  Evan S Dellon; Olga Speck; Kimberly Woodward; Jessica H Gebhart; Ryan D Madanick; Sidney Levinson; Karen J Fritchie; John T Woosley; Nicholas J Shaheen
Journal:  Am J Gastroenterol       Date:  2013-10-22       Impact factor: 10.864

Review 9.  Efficacy of Proton Pump Inhibitor Drugs for Inducing Clinical and Histologic Remission in Patients With Symptomatic Esophageal Eosinophilia: A Systematic Review and Meta-Analysis.

Authors:  Alfredo J Lucendo; Ángel Arias; Javier Molina-Infante
Journal:  Clin Gastroenterol Hepatol       Date:  2015-08-03       Impact factor: 11.382

10.  A pilot study of omalizumab in eosinophilic esophagitis.

Authors:  Denise Loizou; Benjamin Enav; Edina Komlodi-Pasztor; Pamela Hider; Julie Kim-Chang; Laura Noonan; Tabitha Taber; Suhasini Kaushal; Renuka Limgala; Margaret Brown; Raavi Gupta; Nader Balba; Ozlem Goker-Alpan; Amer Khojah; Oral Alpan
Journal:  PLoS One       Date:  2015-03-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.